Radiotherapeutic pharmaceutical.
Ended Awarded
- Contract number
- HT009022FG0910097
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3 Part of Sofie Biosciences, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $45,448
Award facts
- Contract value 100% obligated
- $45,448.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
About this award
Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $45,448 firm fixed price call against the Biopharmaceutical Product Application blanket purchase agreement by the Defense Health Agency. The contract is for the delivery of radiotherapeutic pharmaceutical products to support DHA medical programs through September 30, 2022. Performance will take place in Sterling, Virginia. No set-aside designation was applied to this award to fulfill the stated requirement.
Quick answers
Who was awarded contract HT009022FG0910097?
HT009022FG0910097 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on September 13, 2022.
How much is contract HT009022FG0910097 worth?
The government has obligated $45,448 on HT009022FG0910097.
Is contract HT009022FG0910097 an order under another contract?
Yes. HT009022FG0910097 is a BPA call under HT001421A0014, a blanket purchase agreement.
Was contract HT009022FG0910097 competed?
The extent of competition for HT009022FG0910097 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award